Trial: 201903162

Phase II Study of Optune Device – TT Fields plus Nivolumab and Ipilimumab for Melanoma with Brain Metastasis

Phase

II

Principal Investigator

Ansstas, George

Disease Site

Melanoma, Skin

Learn more about this study at: clinicaltrials.gov